Monitoring the Safety & Effectiveness of COVID-19 Vaccines and Vaccination

As the world continues to face the public health, social, and economic unravelling due to the COVID-19 crisis, it should be clear that, to overcome the pandemic, a large share of the world needs to be immune to the virus.  The World Bank Group is helping developing countries purchase and distribute vaccines and strengthen health systems through a $12 billion vaccine financing facility, which complements the $6 billion Global COVID-19 Strategic Preparedness and Response Program in the health sector approved in April 2020 and that now covers more than 110 countries.  

Continue reading

World Bank Support for Country Access to COVID-19 Vaccines

As of May 13, 2021, the World Bank Board approved operations to support vaccine

Kuala Lumpur, Malaysia. 03rd Mar, 2021. A healthcare worker holds a vial of the Pfizer-BioNTech Covid-19 vaccine during the first phase of the country nationwide vaccination drive at the Hospital UiTM in Sungai Buloh, outskirts of Kuala Lumpur. Credit: SO

rollout in 22 countries amounting to $2.4 billion.  See the latest project financing, project documents and procurement information in the list below. More information will be shared here as it becomes available. We expect to reach 50 countries amounting to $4 billion by mid-year.

Continue reading

Webinar Recap WBG/IMF Spring Meetings

Key Green Transitions: How Systems Are Changing for People and Planet

#GreenRecoveryWBG

Everyone should be able to live a sustainable life on a healthy planet. But the last six years have been the hottest on record. Record-breaking wildfires, droughts, floods and hurricanes have taken lives, damaged homes, hospitals and businesses. Meanwhile, COVID-19 took a heavy health and economic toll and pushed millions into extreme poverty.

COVID-19: Vaccines for Developing Countries

The rollout of COVID-19 vaccines in developing countries is critical to protecting lives, building human capital, and stimulating economic recovery. The current crisis is exacerbating inequalities throughout the world and, without access to vaccines, the gap will widen further.This event begins with voices of youth from around the world reflecting on the impact of the pandemic and their hopes for a speedy recovery with a return to school, friends, and family.World Bank Group President David Malpass then describes what vaccines mean for the world, what needs to be done to accelerate production and ensure safe and effective distribution to developing countries, and the importance of collaboration amongst all stakeholders for a sustainable and inclusive recovery

 

Webinar April 9th – COVID-19: Vaccines for Developing Countries

About the Event: LINK

The rollout of COVID-19 vaccines in developing countries is critical to protecting lives, building human capital, and stimulating economic recovery. The current crisis is exacerbating inequalities throughout the world and, without access to vaccines, the gap will widen further. Ensuring developing countries can access, as well as safely distribute vaccines, calls for strong partnership and cooperation at the national, regional & global levels. This event will explore:  

Continue reading

Assessing Country Readiness for COVID-19 Vaccines – First Insights from the Assessment Rollout

The global COVID-19 vaccination campaign will be the largest in history. The delivery of

Kuala Lumpur, Malaysia. 03rd Mar, 2021. A healthcare worker holds a vial of the Pfizer-BioNTech Covid-19 vaccine during the first phase of the country nationwide vaccination drive at the Hospital UiTM in Sungai Buloh, outskirts of Kuala Lumpur. Credit: SO

COVID-19 vaccines presents challenges unprecedented in scale, speed and specificities, especially in low- and middleincome countries. In November 2020, anticipating the availability of safe and effective vaccines for COVID-19, the World  Bank together with WHO, UNICEF, the Global Fund, and Gavi rolled out readiness assessments in more than 100 low and middle-income countries.

Continue reading

We must prepare supply chains for future COVID-19 vaccines and therapeutics

Nothing would undermine delivery of successful COVID-19 (coronavirus) vaccines and gs1_forumtherapeutic treatments faster than the emergence of fake vaccines.  Health development and financing institutions already have their work cut out to raise public awareness and acceptance of these potential pandemic ending-solutions. The proliferation of falsified versions in marketplaces around the world would make the job even harder. The likely diversion of these highly prized commodities away from priority or underserved recipients would also be tragic. COVID-19 vaccines and therapeutics could be the catalyst to step up efforts around medicine traceability, but supply chains need to make fast progress. 

Continue reading